Millennium Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Millennium Management’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-31,700	Closed	-$68.2K	–	6801
2024 Q3	$68.2K	Sell	31,700 -31,314	-50%	-$112K	﹤0.01%	5652
2024 Q2	$325K	Sell	63,014 -198,069	-76%	-$1.04M	﹤0.01%	4866
2024 Q1	$1.4M	Buy	+261,083	New	+$1.81M	﹤0.01%	4028
2023 Q3	–	Sell	-12,825	Closed	-$40.4K	–	6859
2023 Q2	$40.4K	Sell	12,825 -65,511	-84%	-$211K	﹤0.01%	5513
2023 Q1	$209K	Sell	78,336 -13,137	-14%	-$50.9K	﹤0.01%	5146
2022 Q4	$328K	Buy	91,473 +21,839	+31%	+$94.8K	﹤0.01%	5033
2022 Q3	$448K	Sell	69,634 -26,776	-28%	-$218K	﹤0.01%	5057
2022 Q2	$928K	Buy	96,410 +45,228	+88%	+$423K	﹤0.01%	4430
2022 Q1	$609K	Buy	51,182 +41,952	+455%	+$750K	﹤0.01%	4968
2021 Q4	$301K	Sell	9,230 -22,408	-71%	-$907K	﹤0.01%	5538
2021 Q3	$1.41M	Sell	31,638 -24,133	-43%	-$1.18M	﹤0.01%	4302
2021 Q2	$3.04M	Buy	55,771 +38,892	+230%	+$2.3M	﹤0.01%	3419
2021 Q1	$1.26M	Sell	16,879 -21,148	-56%	-$2.2M	﹤0.01%	3993
2020 Q4	$4.13M	Buy	38,027 +22,924	+152%	+$2.09M	0.01%	2630
2020 Q3	$1.33K	Sell	15,103 -203	-1%	-$23.1K	﹤0.01%	2921
2020 Q2	$1.63M	Buy	+15,306	New	+$1.37M	﹤0.01%	2668
2020 Q1	–	Sell	-52,559	Closed	-$3.63M	–	4646
2019 Q4	$3.63M	Buy	52,559 +50,681	+2,699%	+$3.07M	0.01%	2177
2019 Q3	$194K	Buy	+1,878	New	+$177K	﹤0.01%	3804
2019 Q2	–	Sell	-6,972	Closed	-$637K	–	4569
2019 Q1	$637K	Sell	6,972 -2,647	-28%	-$184K	﹤0.01%	3120
2018 Q4	$536K	Sell	9,619 -7,666	-44%	-$582K	﹤0.01%	2925
2018 Q3	$2.06M	Sell	17,285 -20,262	-54%	-$2.35M	﹤0.01%	2415
2018 Q2	$3.83M	Buy	37,547 +21,170	+129%	+$2.62M	0.01%	1972
2018 Q1	$2.13M	Buy	+16,377	New	+$1.79M	﹤0.01%	2273
2017 Q4	–	Sell	-11,321	Closed	-$1.67M	–	4146
2017 Q3	$1.67M	Buy	+11,321	New	+$2.13M	﹤0.01%	2262
2017 Q2	–	Sell	-1,165	Closed	-$186K	–	3967
2017 Q1	$186K	Buy	+1,165	New	+$142K	﹤0.01%	3229